• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Biliary phosphatidylcholine and lysophosphatidylcholine profiles in sclerosing cholangitis.原发性硬化性胆管炎中的胆汁磷脂酰胆碱和溶血磷脂酰胆碱谱。
World J Gastroenterol. 2013 Sep 7;19(33):5454-63. doi: 10.3748/wjg.v19.i33.5454.
2
Alterations of the bile microbiome in primary sclerosing cholangitis.原发性硬化性胆管炎胆汁微生物组的改变。
Gut. 2020 Apr;69(4):665-672. doi: 10.1136/gutjnl-2019-318416. Epub 2019 Jun 26.
3
Differences in phosphatidylcholine and bile acids in bile from Egyptian and UK patients with and without cholangiocarcinoma.埃及和英国胆管癌患者和非胆管癌患者胆汁中磷脂酰胆碱和胆汁酸的差异。
HPB (Oxford). 2011 Jun;13(6):385-90. doi: 10.1111/j.1477-2574.2011.00296.x. Epub 2011 Mar 22.
4
Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis.新型血清和胆汁蛋白标志物可预测原发性硬化性胆管炎的疾病严重程度和预后。
J Hepatol. 2017 Jun;66(6):1214-1222. doi: 10.1016/j.jhep.2017.01.019. Epub 2017 Feb 2.
5
Unique bile acid profiles in the bile ducts of patients with primary sclerosing cholangitis.原发性硬化性胆管炎患者胆管中独特的胆汁酸谱。
Hepatol Commun. 2024 May 22;8(6). doi: 10.1097/HC9.0000000000000452. eCollection 2024 Jun 1.
6
Microbiological analysis of bile and its impact in critically ill patients with secondary sclerosing cholangitis.胆汁的微生物分析及其对继发硬化性胆管炎危重症患者的影响。
J Infect. 2015 May;70(5):483-90. doi: 10.1016/j.jinf.2015.01.013. Epub 2015 Feb 7.
7
Pathological features of primary sclerosing cholangitis identified by bile proteomic analysis.原发性硬化性胆管炎的胆汁蛋白质组学分析鉴定的病理特征。
Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt B):1380-1389. doi: 10.1016/j.bbadis.2017.09.012. Epub 2017 Sep 22.
8
Bile duct bacterial isolates in primary sclerosing cholangitis: a study of explanted livers.原发性硬化性胆管炎中的胆管细菌分离株:一项对移植肝脏的研究。
J Hepatol. 1998 Mar;28(3):426-32. doi: 10.1016/s0168-8278(98)80316-4.
9
Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a pilot study.原发性胆汁性肝硬化和原发性硬化性胆管炎患者血清中 17 种胆汁酸的代谢组学分析:一项初步研究。
Dig Liver Dis. 2012 Apr;44(4):303-10. doi: 10.1016/j.dld.2011.10.025. Epub 2011 Dec 9.
10
Lipidomic profiling of bile in distinguishing benign from malignant biliary strictures: a single-blinded pilot study.胆汁脂质组学分析鉴别良恶性胆道狭窄:一项单盲先导研究。
Am J Gastroenterol. 2014 Jun;109(6):895-902. doi: 10.1038/ajg.2014.60. Epub 2014 Apr 8.

引用本文的文献

1
Genetically predicted gut microbiota mediate the association between plasma lipidomics and primary sclerosing cholangitis.遗传预测的肠道微生物组介导了血浆脂质组学与原发性硬化性胆管炎之间的关联。
BMC Gastroenterol. 2024 May 8;24(1):158. doi: 10.1186/s12876-024-03246-3.
2
Primary Sclerosing Cholangitis-Associated Cholangiocarcinoma: From Pathogenesis to Diagnostic and Surveillance Strategies.原发性硬化性胆管炎相关胆管癌:从发病机制到诊断与监测策略
Cancers (Basel). 2023 Oct 11;15(20):4947. doi: 10.3390/cancers15204947.
3
Phosphatidylcholine in bile-derived small extracellular vesicles as a novel biomarker of cholangiocarcinoma.胆汁来源的小细胞外囊泡中的磷脂酰胆碱作为胆管癌的新型生物标志物。
Cancer Med. 2023 Jun;12(12):13007-13018. doi: 10.1002/cam4.5973. Epub 2023 Apr 25.
4
Bile Acids and Biliary Fibrosis.胆汁酸与胆汁性纤维化。
Cells. 2023 Mar 2;12(5):792. doi: 10.3390/cells12050792.
5
Changes in beta-catenin expression and activation during progression of primary sclerosing cholangitis predict disease recurrence.原发性硬化性胆管炎进展过程中β-连环蛋白表达和激活的变化可预测疾病复发。
Sci Rep. 2022 Jan 7;12(1):206. doi: 10.1038/s41598-021-04358-6.
6
The neglected biliary mucus and its phosphatidylcholine content: a putative player in pathogenesis of primary cholangitis-a narrative review article.被忽视的胆汁黏液及其磷脂酰胆碱含量:原发性胆管炎发病机制中的一个潜在因素——一篇叙述性综述文章
Ann Transl Med. 2021 Apr;9(8):738. doi: 10.21037/atm-20-3591.
7
The Gut-Liver Axis in Cholestatic Liver Diseases.胆汁淤积性肝病中的肠-肝轴。
Nutrients. 2021 Mar 21;13(3):1018. doi: 10.3390/nu13031018.
8
Lipid antigens in bile from patients with chronic liver diseases activate natural killer T cells.胆汁中的脂质抗原可激活慢性肝病患者的自然杀伤 T 细胞。
Clin Exp Immunol. 2021 Feb;203(2):304-314. doi: 10.1111/cei.13541. Epub 2020 Nov 16.
9
Pilot Multi-Omic Analysis of Human Bile from Benign and Malignant Biliary Strictures: A Machine-Learning Approach.良性和恶性胆管狭窄患者胆汁的多组学初步分析:一种机器学习方法
Cancers (Basel). 2020 Jun 21;12(6):1644. doi: 10.3390/cancers12061644.
10
Characterisation of the Serum Metabolic Signature of Cholangiocarcinoma in a United Kingdom Cohort.英国队列中胆管癌血清代谢特征的表征
J Clin Exp Hepatol. 2020 Jan-Feb;10(1):17-29. doi: 10.1016/j.jceh.2019.06.001. Epub 2019 Jun 15.

本文引用的文献

1
Health effects of dietary phospholipids.膳食磷脂的健康影响。
Lipids Health Dis. 2012 Jan 5;11:3. doi: 10.1186/1476-511X-11-3.
2
Pathogenesis of primary sclerosing cholangitis.原发性硬化性胆管炎的发病机制。
Best Pract Res Clin Gastroenterol. 2011 Dec;25(6):727-39. doi: 10.1016/j.bpg.2011.10.009.
3
Evolving concepts in primary sclerosing cholangitis.原发性硬化性胆管炎的概念演变。
Liver Int. 2012 Mar;32(3):352-69. doi: 10.1111/j.1478-3231.2011.02607.x. Epub 2011 Aug 17.
4
Hepatocyte IKK2 protects Mdr2-/- mice from chronic liver failure.肝细胞 IKK2 保护 Mdr2-/- 小鼠免于慢性肝衰竭。
PLoS One. 2011;6(10):e25942. doi: 10.1371/journal.pone.0025942. Epub 2011 Oct 14.
5
Differences in phosphatidylcholine and bile acids in bile from Egyptian and UK patients with and without cholangiocarcinoma.埃及和英国胆管癌患者和非胆管癌患者胆汁中磷脂酰胆碱和胆汁酸的差异。
HPB (Oxford). 2011 Jun;13(6):385-90. doi: 10.1111/j.1477-2574.2011.00296.x. Epub 2011 Mar 22.
6
Primary sclerosing cholangitis: overview and update.原发性硬化性胆管炎:概述与最新进展。
Nat Rev Gastroenterol Hepatol. 2010 Nov;7(11):611-9. doi: 10.1038/nrgastro.2010.155. Epub 2010 Oct 12.
7
Endoscopic retrograde cholangiopancreatography in diagnosis and treatment of primary sclerosing cholangitis.内镜逆行胰胆管造影术在原发性硬化性胆管炎的诊断和治疗中的应用。
Clin Liver Dis. 2010 May;14(2):349-58. doi: 10.1016/j.cld.2010.03.010.
8
Alterations of phospholipid concentration and species composition of the intestinal mucus barrier in ulcerative colitis: a clue to pathogenesis.溃疡性结肠炎中肠道黏液屏障的磷脂浓度和种类组成的改变:发病机制的线索。
Inflamm Bowel Dis. 2009 Nov;15(11):1705-20. doi: 10.1002/ibd.20993.
9
Secondary sclerosing cholangitis.继发性硬化性胆管炎
Nat Rev Gastroenterol Hepatol. 2009 May;6(5):287-95. doi: 10.1038/nrgastro.2009.46.
10
Biliary lipids and cholesterol gallstone disease.胆汁脂质与胆固醇胆结石病
J Lipid Res. 2009 Apr;50 Suppl(Suppl):S406-11. doi: 10.1194/jlr.R800075-JLR200. Epub 2008 Nov 17.

原发性硬化性胆管炎中的胆汁磷脂酰胆碱和溶血磷脂酰胆碱谱。

Biliary phosphatidylcholine and lysophosphatidylcholine profiles in sclerosing cholangitis.

机构信息

Annika Gauss, Robert Ehehalt, Karl-Heinz Weiss, Yvonne Schaefer, Petra Kloeters-Plachky, Adolf Stiehl, Wolfgang Stremmel, Peter Sauer, Daniel Nils Gotthardt, Gastroenterology and Hepatology Unit, Department of Internal Medicine, University Hospital Heidelberg, 69120 Heidelberg, Germany.

出版信息

World J Gastroenterol. 2013 Sep 7;19(33):5454-63. doi: 10.3748/wjg.v19.i33.5454.

DOI:10.3748/wjg.v19.i33.5454
PMID:24023488
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3761098/
Abstract

AIM

To analyze phospholipid profiles in intrahepatic bile from patients with primary sclerosing cholangitis (PSC) and secondary sclerosing cholangitis (SSC).

METHODS

Intrahepatic bile specimens collected via endoscopic retrograde cholangiography from 41 patients were analyzed. Fourteen of these patients were diagnosed with PSC, 10 with SSC, 11 with choledocholithiasis or no identifiable biliary disease, and 6 with cholangiocellular carcinoma (CCC). Bile acid, cholesterol, protein, and bilirubin contents as well as pancreas lipase activity in bile were determined by biochemical methods. Phosphatidylcholine (PC) and lysophosphatidylcholine (LPC) species were quantified using nano-electrospray ionization tandem mass spectrometry.

RESULTS

Bile from all the examined patient groups showed a remarkably similar PC and LPC species composition, with only minor statistical differences. Total biliary PC concentrations were highest in controls (8030 ± 1843 μmol/L) and lowest in patients with CCC (1969 ± 981 μmol/L) (P = 0.005, controls vs SSC and CCC, respectively, P < 0.05). LPC contents in bile were overall low (4.2% ± 1.8%). Biliary LPC/PC ratios and ratios of biliary PC to bilirubin, PC to cholesterol, PC to protein, and PC to bile acids showed no intergroup differences.

CONCLUSION

PC and LPC profiles being similar in patients with or without sclerosing cholangitis, these phospholipids are likely not of major pathogenetic importance in this disease group.

摘要

目的

分析原发性硬化性胆管炎(PSC)和继发性硬化性胆管炎(SSC)患者肝内胆汁中的磷脂谱。

方法

通过内镜逆行胰胆管造影术收集 41 名患者的肝内胆汁标本进行分析。其中 14 名患者被诊断为 PSC,10 名患者为 SSC,11 名患者为胆总管结石或无明确胆道疾病,6 名患者为胆管细胞癌(CCC)。通过生化方法测定胆汁中的胆汁酸、胆固醇、蛋白质和胆红素含量以及胰腺脂肪酶活性。采用纳喷雾电离串联质谱法定量检测磷脂酰胆碱(PC)和溶血磷脂酰胆碱(LPC)。

结果

所有受检患者组的胆汁均显示出非常相似的 PC 和 LPC 种类组成,仅存在微小的统计学差异。总胆汁 PC 浓度在对照组中最高(8030 ± 1843 μmol/L),在 CCC 患者中最低(1969 ± 981 μmol/L)(P = 0.005,分别为对照组与 SSC 和 CCC,P < 0.05)。胆汁中的 LPC 含量总体较低(4.2% ± 1.8%)。胆汁 LPC/PC 比值以及胆汁 PC 与胆红素、PC 与胆固醇、PC 与蛋白质和 PC 与胆汁酸的比值在各组间无差异。

结论

在有或没有硬化性胆管炎的患者中,PC 和 LPC 谱相似,这些磷脂在该疾病组中可能不是主要的发病机制重要因素。